Innovation
1 patent family (1 granted) — focus: Human necessities; filing pace accelerating. Cited 19 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Social engagement
Social engagement: 178 social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
7 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 14% |
| Private equity | 1 | 14% |
| Other / undisclosed | 5 | 71% |
Recent activity
19 Nov 2025
Partnership
Takeda Pharmaceutical Company